Author: admin

JanOne Completes Pre-IND Meeting with FDA on Jan123

April 18, 2023

JanOne to Present Data On Its Two Non-Opioid Drug Candidates at The Appalachian Region Spine and Pain Meeting on Drug Development Programs to Treat Pain on April 15, 2023

April 13, 2023

JanOne Technologies Announces Registered Direct Offering of Common Stock Priced At-The-Market

March 24, 2023

JanOne Sells Legacy Business ARCA Recycling to Concentrate on Growing BioPharm Businesses

March 22, 2023

JanOne to Present Important Trial Results at Annual Meeting of American Society of Interventional Pain Physicians

February 22, 2023

JanOne Charts Ambitious Strategic Course for Non-Addictive Pain Management

January 26, 2023

JanOne Inc. Completes Acquisition of Soin Therapeutics, LLC

January 10, 2023

JanOne Inc. Executes Term Sheet to Acquire Soin Therapeutics LLC

September 22, 2022

JanOne Inc. Announces an Improved Formulation of JAN101

June 28, 2022

JanOne Inc. Announces the Issuance of U.S. Patent Covering a Method of Improving Nerve Function Using JAN101

June 7, 2022